Derrick Sung

Derrick Sung

Finansdirektör/CFO på PULMONX CORPORATION

Förmögenhet: 175 915 $ per 2026-06-30

53 år
Health Technology
Consumer Services
Finance

Profil

Derrick Sung is currently Director at Sensydia Corp.
since 2018, Chief Financial Officer at Aerin Medical, Inc. since 2023, and Chief Operating & Financial Officer at Pulmonx Corp.
starting in 2025.
Former positions include Director-Marketing & Business Development at Boston Scientific Corp.
from 2004 to 2008, Independent Director at Minerva Surgical, Inc. from 2022 to 2024, Chief Financial & Accounting Officer at Pulmonx Corp.
from 2019 to 2023, Executive VP-Strategy & Corporate Development at iRhythm Holdings, Inc. from 2015 to 2019, Senior Research Analyst at Sanford C.
Bernstein & Co. LLC from 2008 to 2014, Principal at Vascular Intervention, and Principal at The Boston Consulting Group, Inc. from 2000 to 2004.
Education includes undergraduate studies at Stanford University, an MBA from San Diego State University, and a doctorate from the University of California San Diego.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-03-15 135 319 ( 0,32 % ) 175 915 $ 2026-06-30

Aktiva positioner av Derrick Sung

FöretagPositionStart
PULMONX CORPORATION Finansdirektör/CFO 2025-11-03
Finansdirektör/CFO 2023-11-20
Direktör/Styrelseledamot 2018-08-01

Tidigare kända positioner av Derrick Sung

FöretagPositionSlut
MINERVA SURGICAL, INC. Direktör/Styrelseledamot 2024-01-01
PULMONX CORPORATION Finansdirektör/CFO 2023-10-10
IRHYTHM HOLDINGS, INC. Företagsledare/Principal 2019-05-01
BOSTON SCIENTIFIC CORPORATION Försäljning & Marknadsföring 2008-01-01
Företagsledare/Principal 2004-01-01
Se detaljerna i Derrick Sungs erfarenhet

Derrick Sungs utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

70

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Finance

Consumer Services

Consumer Services

Vascular Intervention

Finance

  1. Börsen
  2. Insiders
  3. Derrick Sung